Sue E. Knoblaugh

3.4k total citations · 1 hit paper
47 papers, 2.5k citations indexed

About

Sue E. Knoblaugh is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sue E. Knoblaugh has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Sue E. Knoblaugh's work include Veterinary Oncology Research (4 papers), Cancer Research and Treatments (4 papers) and Hedgehog Signaling Pathway Studies (4 papers). Sue E. Knoblaugh is often cited by papers focused on Veterinary Oncology Research (4 papers), Cancer Research and Treatments (4 papers) and Hedgehog Signaling Pathway Studies (4 papers). Sue E. Knoblaugh collaborates with scholars based in United States, South Africa and Japan. Sue E. Knoblaugh's co-authors include Jeffrey J. Delrow, Tobias M. Hohl, James M. Olson, Günter J. Hämmerling, Dirk G. Brockstedt, Mary Philip, Andrea Schietinger, Todd D. Schell, Edison Y. Chiu and Philip D. Greenberg and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Sue E. Knoblaugh

45 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis

2016 484 citations Andrea Schietinger, Mary Philip et al. Immunity profile →

Peers

Countries citing papers authored by Sue E. Knoblaugh

Since Specialization

Citations

This map shows the geographic impact of Sue E. Knoblaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue E. Knoblaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue E. Knoblaugh more than expected).

Fields of papers citing papers by Sue E. Knoblaugh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue E. Knoblaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue E. Knoblaugh. The network helps show where Sue E. Knoblaugh may publish in the future.

Co-authorship network of co-authors of Sue E. Knoblaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Sue E. Knoblaugh. A scholar is included among the top collaborators of Sue E. Knoblaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue E. Knoblaugh. Sue E. Knoblaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mitochondrial diabetes in mice expressing a dominant-negative allele of nuclear respiratory factor-1 (Nrf1) in pancreatic β-cells 2024 ·Biochemical and Biophysical Research Communications ·Fionnuala Morrish, Hélène Gingras, (unknown), Li Huang, Ian R. Sweet, (unknown), Sue E. Knoblaugh, David M. Hockenbery	0
2	Bioorthogonal non-canonical amino acid tagging to track transplanted human induced pluripotent stem cell-specific proteome 2024 ·Stem Cell Research & Therapy ·(unknown), Julie Dougherty, (unknown), (unknown), Syed Baseeruddin Alvi, Ki Ho Park, (unknown), Sue E. Knoblaugh, Harpreet Singh, Elizabeth D. Kirby, Mahmood Khan	1
3	KMT2D loss drives aggressive tumor phenotypes in cutaneous squamous cell carcinoma. 2022 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Abigail J. Beer, Johnny R. Ramroop, (unknown), Dawn C. Allain, Reena Shakya, Sue E. Knoblaugh, (unknown), Amanda E. Toland	12
4	Facilitative lysosomal transport of bile acids alleviates ER stress in mouse hematopoietic precursors 2021 ·Nature Communications ·Avinash K. Persaud, (unknown), (unknown), (unknown), (unknown), Debasis Nayak, Craig A. McElroy, Shanmugam Muruganandan, Sue E. Knoblaugh, Xiaolin Cheng, Rajgopal Govindarajan	10
5	Nonhelical Helicobacter pylori Mutants Show Altered Gland Colonization and Elicit Less Gastric Pathology than Helical Bacteria during Chronic Infection 2019 ·Infection and Immunity ·Laura E. Martínez, Valerie P. O’Brien, (unknown), Sue E. Knoblaugh, Nina R. Salama	15
6	Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice 2019 ·Scientific Reports ·Keith R. Loeb, (unknown), (unknown), (unknown), Sue E. Knoblaugh, Jonathan E. Grim, Luke Drury, Aaron L. Sarver, Adam J. Dupuy, Bruce E. Clurman	6
7	Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis breakdown → 2016 ·Immunity ·Andrea Schietinger, Mary Philip, (unknown), Edison Y. Chiu, Jeffrey J. Delrow, Ryan Basom, Peter Lauer, Dirk G. Brockstedt, Sue E. Knoblaugh, Günter J. Hämmerling, Todd D. Schell, Natalio Garbi, Philip D. Greenberg	484
8	Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors 2015 ·Cancer Research ·Janean L. Fidel, (unknown), William S. Dernell, Stacey Hansen, (unknown), Mark R. Stroud, Joshua I. Molho, Sue E. Knoblaugh, Jeffrey A. Meganck, James M. Olson, Brad Rice, Julia Parrish-Novak	61
9	Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy 2015 ·PLoS ONE ·Joshua Park, Jacqueline Wicki, Sue E. Knoblaugh, Jeffrey S. Chamberlain, Donghoon Lee	15
10	TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation 2014 ·Oncogene ·Sidney M. Morris, Kelly Carter, Ji Yeon Baek, (unknown), Matthew M. Yeh, Sue E. Knoblaugh, William M. Grady	22
11	Inflammatory Monocytes Mediate Early and Organ-Specific Innate Defense During Systemic Candidiasis 2013 ·The Journal of Infectious Diseases ·Lisa Y. Ngo, Shinji Kasahara, Debra K Kumasaka, Sue E. Knoblaugh, Anupam Jhingran, Tobias M. Hohl	107
12	Tracing Conidial Fate and Measuring Host Cell Antifungal Activity Using a Reporter of Microbial Viability in the Lung 2012 ·Cell Reports ·Anupam Jhingran, Katrina B. Mar, Debra K Kumasaka, Sue E. Knoblaugh, Lisa Y. Ngo, Brahm H. Segal, Yoichiro Iwakura, Clifford A. Lowell, Jessica A. Hamerman, Xin Lin, Tobias M. Hohl	90
13	Fbw7 and p53 Cooperatively Suppress Advanced and Chromosomally Unstable Intestinal Cancer 2012 ·Molecular and Cellular Biology ·Jonathan E. Grim, Sue E. Knoblaugh, Katherine A. Guthrie, (unknown), Jherek Swanger, (unknown), Jeffrey J. Delrow, (unknown), William M. Grady, Keiichi I. Nakayama, Bruce E. Clurman	67
14	A Distinct Smoothened Mutation Causes Severe Cerebellar Developmental Defects and Medulloblastoma in a Novel Transgenic Mouse Model 2012 ·Molecular and Cellular Biology ·Joyoti Dey, Sally Ditzler, Sue E. Knoblaugh, Beryl A. Hatton, Janell M. Schelter, Michele A. Cleary, Brig Mecham, Lucy B. Rorke‐Adams, James M. Olson	35
15	Transforming Growth Factor–Beta Signaling Promotes Hepatocarcinogenesis Induced by P53 Loss 2011 ·Hepatology ·Shelli M. Morris, Ji Yeon Baek, (unknown), Samornmas Kanngurn, Sue E. Knoblaugh, William M. Grady	54
16	Correction: Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method 2010 ·PLoS ONE ·(unknown), Omid Veiseh, Narayan Bhattarai, Conroy Sun, Stacey Hansen, Sally Ditzler, Sue E. Knoblaugh, Dong‐Hoon Lee, Richard G. Ellenbogen, Miqin Zhang, James M. Olson	7
17	Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer 2009 ·Oncogene ·Karen S. Kelly‐Spratt, (unknown), Kay E. Gurley, (unknown), Sue E. Knoblaugh, Christopher J. Kemp	37
18	The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread 2008 ·Cancer Research ·Beryl A. Hatton, Elisabeth H. Villavicencio, Karen D. Tsuchiya, Joel I. Pritchard, Sally Ditzler, Barbara Pullar, Stacey Hansen, Sue E. Knoblaugh, Donghoon Lee, Charles G. Eberhart, Andrew R. Hallahan, James M. Olson	137
19	Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium 2008 ·Cancer Research ·Brent W. Sutherland, Sue E. Knoblaugh, Paula Kaplan‐Lefko, Fen Wang, Martin Holzenberger, Norman M. Greenberg	54
20	Reduction of Age-Associated Pathology in Old Mice by Overexpression of Catalase in Mitochondria 2008 ·The Journals of Gerontology Series A ·Piper M. Treuting, Nancy J. Linford, Sue E. Knoblaugh, Mary J. Emond, John Morton, George M. Martin, Peter S. Rabinovitch, Warren Ladiges	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact